Stock KOTRA KOTRA INDUSTRIES
Add to a list
To use this feature you must be a member
Log inSign up

Financials Kotra Industries

Equities

KOTRA

MYQ0002OO004

Pharmaceuticals

End-of-day quote BURSA MALAYSIA
Other stock markets
 23:00:00 29/04/2024 BST 		5-day change 1st Jan Change
4.75 MYR -.--% Intraday chart for Kotra Industries +1.93% -1.66%
02-21 Kotra Industries Berhad Announces Single Tier Interim Dividend for the Financial Year Ending 30 June 2024, Payable on 21 March 2024 CI
02-21 Kotra Industries Berhad Reports Written Off Results for the Second Quarter Ended December 31, 2023 CI

Valuation

Fiscal Period: June 2019 2022 2023 2024 2025 2026
Capitalization 1 253.3 591.9 758.1 704.5 - -
Enterprise Value (EV) 1 253.3 591.9 758.1 704.5 704.5 704.5
P/E ratio 11.2 x 9.54 x 11.6 x 12.6 x 11.8 x 10.2 x
Yield - - 5.08% 4.6% 4.67% 4.95%
Capitalization / Revenue 1.47 x - 3.13 x 2.79 x 2.6 x 2.47 x
EV / Revenue 1.47 x - 3.13 x 2.79 x 2.6 x 2.47 x
EV / EBITDA - - 9.33 x 9.49 x 8.56 x 7.99 x
EV / FCF - - 18.9 x 30.1 x 24.9 x 10.1 x
FCF Yield - - 5.28% 3.32% 4.02% 9.94%
Price to Book - - 2.8 x 2.34 x 2.13 x 1.93 x
Nbr of stocks (in thousands) 143,940 147,974 148,064 148,314 - -
Reference price 2 1.760 4.000 5.120 4.750 4.750 4.750
Announcement Date 22/08/19 29/08/22 23/08/23 - - -
1MYR in Million2MYR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: June 2019 2022 2023 2024 2025 2026
Net sales 1 172.6 - 242.2 252.3 270.5 285
EBITDA 1 - - 81.25 74.2 82.3 88.15
EBIT 1 - - 66.27 60.1 61.4 70.05
Operating Margin - - 27.36% 23.82% 22.7% 24.58%
Earnings before Tax (EBT) 1 - - 66.08 59.2 63.67 72.45
Net income 1 - 62.1 65.23 55.73 59.47 68.86
Net margin - - 26.93% 22.09% 21.99% 24.16%
EPS 2 0.1566 0.4195 0.4408 0.3760 0.4010 0.4650
Free Cash Flow 1 - - 40.01 23.37 28.3 70.01
FCF margin - - 16.52% 9.26% 10.46% 24.56%
FCF Conversion (EBITDA) - - 49.24% 31.5% 34.39% 79.42%
FCF Conversion (Net income) - - 61.33% 41.93% 47.59% 101.67%
Dividend per Share 2 - - 0.2600 0.2183 0.2217 0.2350
Announcement Date 22/08/19 29/08/22 23/08/23 - - -
1MYR in Million2MYR
Estimates

Balance Sheet Analysis

Fiscal Period: June 2019 2022 2023 2024 2025 2026
Net Debt - - - - - -
Net Cash position - - - - - -
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 - - 40 23.4 28.3 70
ROE (net income / shareholders' equity) 13.7% - 25.3% 19.2% 19.1% 19.8%
ROA (Net income/ Total Assets) - - 20.7% 15.4% 14.6% 14.6%
Assets 1 - - 314.7 361.9 407.3 471.6
Book Value Per Share 2 - - 1.830 2.030 2.240 2.470
Cash Flow per Share - - - - - -
Capex 1 - - 39.6 50 50 15
Capex / Sales - - 16.36% 19.82% 18.49% 5.26%
Announcement Date 22/08/19 29/08/22 23/08/23 - - -
1MYR in Million2MYR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Kotra Industries

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
4.75 MYR
Average target price
5.497 MYR
Spread / Average Target
+15.72%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
KOTRA INDUSTRIES Stock Kotra Industries
-1.66% 148M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+29.68% 681B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+21.47% 556B
JOHNSON & JOHNSON Stock Johnson & Johnson
-4.35% 361B
MERCK & CO., INC. Stock Merck & Co., Inc.
+17.65% 325B
ABBVIE INC. Stock AbbVie Inc.
+3.77% 285B
ASTRAZENECA PLC Stock AstraZeneca PLC
+14.40% 235B
NOVARTIS AG Stock Novartis AG
+4.27% 199B
ROCHE HOLDING AG Stock Roche Holding AG
-11.04% 189B
PFIZER, INC. Stock Pfizer, Inc.
-3.79% 157B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. KOTRA Stock
  4. Financials Kotra Industries